Financhill
Sell
42

PLSE Quote, Financials, Valuation and Earnings

Last price:
$18.73
Seasonality move :
36.63%
Day range:
$17.48 - $18.63
52-week range:
$6.60 - $22.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
27.90x
Volume:
118.1K
Avg. volume:
193.6K
1-year change:
44.79%
Market cap:
$1B
Revenue:
--
EPS (TTM):
-$0.81

Analysts' Opinion

  • Consensus Rating
    Pulse Biosciences has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of --, Pulse Biosciences has an estimated downside of -72.72% from its current price of $18.33.
  • Price Target Upside
    According to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $18.33.

Fair Value

  • According to the consensus of 0 analysts, Pulse Biosciences has -72.72% downside to fair value with a price target of -- per share.

PLSE vs. S&P 500

  • Over the past 5 trading days, Pulse Biosciences has underperformed the S&P 500 by -7.46% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Pulse Biosciences does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Pulse Biosciences has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Pulse Biosciences reported revenues of --.

Earnings Growth

  • Pulse Biosciences has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Pulse Biosciences reported earnings per share of -$0.18.
Enterprise value:
977.4M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-26.90x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-03-31 2023-03-31 2024-03-31 2023-03-31 2024-03-31
Income Statement
Revenue -- -- -- -- --
Gross Profit -$1M -- -- -- --
Operating Income -$61.8M -$50.3M -$44.6M -$9.6M -$10.6M
EBITDA -$60.6M -$49M -$43.4M -$9.3M -$10.3M
Diluted EPS -$2.16 -$1.44 -$0.81 -$0.26 -$0.18
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Balance Sheet
Current Assets $16.4M $62M $22.2M $54.9M $35.8M
Total Assets $31.8M $80.6M $39.5M $70.2M $49.2M
Current Liabilities $3.4M $8.5M $8.9M $7M $5.1M
Total Liabilities $10.1M $60.2M $18.7M $80.9M $12.9M
Total Equity $21.8M $20.4M $20.8M -$10.7M $36.3M
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-03-31 2023-03-31 2024-03-31 2023-03-31 2024-03-31
Cash Flow Statement
Cash Flow Operations -$58M -$38M -$36.3M -$6.6M -$9.8M
Cash From Investing -$665K -$161K -$87K -$39K -$5K
Cash From Financing $11.5M $79.6M $17.1M -$432K $305K
Free Cash Flow -$58.7M -$38.2M -$36.3M -$6.6M -$9.8M
PLSE
Sector
Market Cap
$1B
$46.1M
Price % of 52-Week High
80.78%
46.02%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
44.79%
-30.52%
Beta (5-Year)
1.783
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $18.16
200-day SMA
Buy
Level $14.29
Bollinger Bands (100)
Buy
Level 16.03 - 19.37
Chaikin Money Flow
Sell
Level -8.7M
20-day SMA
Sell
Level $18.83
Relative Strength Index (RSI14)
Buy
Level 50.77
ADX Line
Buy
Level 11.32
Williams %R
Neutral
Level -54.3779
50-day SMA
Buy
Level $17.86
MACD (12, 26)
Sell
Level -0.03
25-day Aroon Oscillator
Buy
Level 20
On Balance Volume
Neutral
Level 9.3M

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (10)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Stock Forecast FAQ

In the current month, PLSE has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PLSE average analyst price target in the past 3 months is --.

  • Where Will Pulse Biosciences Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Pulse Biosciences share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Pulse Biosciences?

    Analysts are divided on their view about Pulse Biosciences share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Pulse Biosciences is a Sell and believe this share price will rise from its current level to --.

  • What Is Pulse Biosciences's Price Target?

    The price target for Pulse Biosciences over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is PLSE A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Pulse Biosciences is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of PLSE?

    You can purchase shares of Pulse Biosciences via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Pulse Biosciences shares.

  • What Is The Pulse Biosciences Share Price Today?

    Pulse Biosciences was last trading at $18.73 per share. This represents the most recent stock quote for Pulse Biosciences. Yesterday, Pulse Biosciences closed at $18.33 per share.

  • How To Buy Pulse Biosciences Stock Online?

    In order to purchase Pulse Biosciences stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
60
QMCO alert for Dec 26

Quantum [QMCO] is up 49.62% over the past day.

Buy
53
ARQQ alert for Dec 26

Arqit Quantum [ARQQ] is up 49.85% over the past day.

Buy
65
TSLL alert for Dec 26

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 3.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock